Revelation Biosciences Inc. (REVBW) Financial Statements (2026 and earlier)

Company Profile

Business Address 4660 LAJOLLA VILLAGE DRIVE
SAN DIEGO, CA 92122
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,700,3316,499,01811,991,7015,252,97978,532537,021
Cash and cash equivalent10,700,3316,499,01811,991,7015,252,97978,53211,734
Short-term investments      525,287
Prepaid expense     4,834114,270
Deferred costs   71,13387,171  
Other undisclosed current assets111,29766,69984,69173,132  
Total current assets:10,811,6286,565,71712,147,5255,413,28283,366651,291
Noncurrent Assets
Operating lease, right-of-use asset722,288     
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization18,06756,33265,08490,133  
Asset, held-in-trust     48,302,52173,510,915
Other noncurrent assets30,941     
Total noncurrent assets:771,29656,33265,08490,13348,302,52173,510,915
TOTAL ASSETS:11,582,9246,622,04912,212,6095,503,41548,385,88774,162,206
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,975,1451,911,4212,512,3581,539,7022,321,51433,772
Accounts payable577,501783,6211,359,898554,205784,800 
Accrued liabilities1,397,6441,127,8001,152,460985,4971,536,71433,772
Derivative instruments and hedges, liabilities     2,390,2583,399,878
Due to related parties✕✕✕✕ 774,345 
Other undisclosed current liabilities23,0132,2463,052,5362,911,260  
Total current liabilities:1,998,1581,913,6675,564,8944,450,9625,486,1173,433,650
Noncurrent Liabilities
Liabilities, other than long-term debt723,771   2,911,2602,911,260
Deferred revenue     2,911,2602,911,260
Operating lease, liability723,771     
Total noncurrent liabilities:723,771   2,911,2602,911,260
Total liabilities:2,721,9291,913,6675,564,8944,450,9628,397,3776,344,910
Temporary equity, including noncontrolling interest     47,811,16473,509,325
Equity
Equity, attributable to parent8,860,9954,708,3826,647,7151,052,453(7,822,654)(5,692,029)
Common stock1,5845222656831,8201,820
Additional paid in capital58,278,69845,213,49832,114,55226,398,618  
Accumulated deficit(49,419,287)(40,505,638)(25,467,102)(25,346,848)(7,824,474)(5,693,849)
Total equity:8,860,9954,708,3826,647,7151,052,453(7,822,654)(5,692,029)
TOTAL LIABILITIES AND EQUITY:11,582,9246,622,04912,212,6095,503,41548,385,88774,162,206

Income Statement (P&L) (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Gross profit:(1,592,860)(390,022)    
Operating expenses(9,070,814)(7,975,109)(8,656,664)(10,864,511)(3,088,248)(145,492)
Other undisclosed operating income1,592,860390,022    
Operating loss:(9,070,814)(7,975,109)(8,656,664)(10,864,511)(3,088,248)(145,492)
Nonoperating income (expense)157,165(7,063,427)8,536,41034,962957,845(1,485,008)
Other nonoperating income (expense)155,007(7,144,868)207,47334,962957,623(1,485,008)
Interest and debt expense     (41,759) 
Loss from continuing operations:(8,913,649)(15,038,536)(120,254)(10,829,549)(2,172,162)(1,630,500)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(2,172,162)(1,630,500)
Other undisclosed net income     41,537 
Net loss attributable to parent:(8,913,649)(15,038,536)(120,254)(10,829,549)(2,130,625)(1,630,500)
Preferred stock dividends and other adjustments     (6,896) 
Other undisclosed net income (loss) available to common stockholders, basic(5,951,528)   2,144,417 
Net income (loss) available to common stockholders, diluted:(14,865,177)(15,038,536)(120,254)(10,829,549)6,896(1,630,500)

Comprehensive Income (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(8,913,649)(15,038,536)(120,254)(10,829,549)(2,130,625)(1,630,500)
Comprehensive loss, net of tax, attributable to parent:(8,913,649)(15,038,536)(120,254)(10,829,549)(2,130,625)(1,630,500)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: